ELDN Insider Trading - Eledon Pharmaceuticals, Inc.

已發行股份	77,187,823 shares
內部人士股份	27,921,493 shares
內部持股	36.17 %
所有內部人士	49

內部人士情緒分數

「內部人士情緒分數」用於查找被公司內部人士購入的公司。

它是一個複雜的多因素量化模型的結果，該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例，以及內部人士擁有的總股份的指標。該分數的範圍從0到100，數值越高表示相對於同行業而言具有更高程度的內部人士持股水平，50為平均值。

更新頻率：每日

查閱「內部人士首選」，該清單呈現被內部人士購入最多的公司。

查閲高排名股票

高管情緒分數

「高管情緒分數」用於查找被公司管理層購入的公司。

根據定義，公司高管是公司內部人士，但與其他內部人士（10%的股東和董事會成員）不同，公司高管每天在公司工作，而且他們使用自己的資金進行交易。（10%的股東和董事會成員通常是基金經理，管理著其他人的資金。）因此，公司高管進行的內幕交易更為重要性，應該被適當地重視和關注。

如同「內部人士情緒分數」，「高管情緒分數」也是一個複雜的多因素量化模型的計算結果，該模型能夠辨識具有最高高管累積持有水平的公司。

更新頻率：每日

查閱「內部人士首選」，該清單呈現被內部人士購入最多的公司。

查閲高排名股票

關鍵內部人士指標

此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。

舉例來說，一般認為內部人士的買入是一個積極的指標，因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少（甚至有內部人士賣出）的公司。

內部人士買入淨數（排名）

0 ( )

2579 out of 10931

內部人士買入淨數是過去90天內買入的內部人士總數減去賣出的內部人士總數。以百分位排名顯示（範圍從0到100%）。

內部人士買入佔流通股比例（排名）

0.000% ( )

2568 out of 10786

內部人士買入佔流通股比例是內部人士在過去90天內購買的股份總數減去賣出的股份總數，除以總流通股數並乘以100。

內幕交易圖表

以下圖表顯示了Eledon Pharmaceuticals, Inc.內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。

內部人員名單及盈利指標

這張表格顯示已知的內部人員名單，從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外，我們還提供了最新披露的持股信息。此外，我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊，請查看YouTube網絡研討會。

See our leaderboard of most profitable insider traders.

內部人士	持股數量	分拆調整
Apple Tree Partners Ii Lp Director, 10% Owner - [D] [10%]	4,218,641	4,218,641
Apple Tree Partners II - Annex, L.P. Director, 10% Owner - [D] [10%]	3,568,438	3,568,438
Apple Tree Partners IV, L.P. Director, 10% Owner - [D] [10%]	250,000	250,000
Timothy J Barberich Director - [D]	121,077	121,077
Biotechnology Value Fund Ii Lp -	113,152	220,460
Biotechnology Value Fund L P -	113,152	220,460
Bvf Gp Holdings Llc 10% Owner - [10%]	113,152	220,460
Bvf I Gp Llc -	113,152	220,460
Bvf Ii Gp Llc -	113,152	220,460
Bvf Inc/il 10% Owner - [10%]	113,152	220,460
Bvf Partners L P/il 10% Owner - [10%]	220,460	220,460
BVF Partners OS Ltd. -	113,152	220,460
Biotechnology Value Trading Fund OS LP -	113,152	220,460
Buckley Stephen Jr. Director - [D]	11,000	11,000
Erez Chimovits Director - [D]	3,183,314	3,183,314
Cheryl Cohen Director - [D]	0	0

內部人士	持股數量	分拆調整
Flesher Gregory J. Chief Executive Officer, Director - [D] [O]	156,918	156,918
Karen Jean Ferrante	62,000
David-Alexandre C Gros Chief Executive Officer, Director - [D] [O]	9,000	9,000
Seth Loring Harrison Director, 10% Owner - [D] [10%]	7,912,079	7,912,079
Jan Hillson Director - [D]	3,430	3,430
Lee Kalowski Chief Financial Officer - [O]	40,953	40,953
Keith Katkin Director - [D]	8,575	8,575
Kessler David A.	12,000
Allan Kirk Director - [D]	3,430	3,430
Jon Kuwahara See Remarks - [O]	5,974	5,974
Mark N Lampert 10% Owner - [10%]	113,152	220,460
Lifesci Index Partners Llc 10% Owner - [10%]	1,065,867	1,065,867
Gary A Lyons Director - [D]	0	0
June Lee Director - [D]	3,430	3,430
Paul Sean Little CHIEF FINANCIAL OFFICER - [O]	10,000	10,000
Logos Global Management LP 10% Owner - [10%]	224,071	224,071

內部人士	持股數量	分拆調整
McBride John S. Director - [D]	3,430	3,430
Jodie Pope Morrison President and CEO, Director - [D] [O]	57,566	57,566
Ag Novartis 10% Owner - [10%]	4,493,458	4,493,458
Bioventures Ltd Novartis 10% Owner - [10%]	4,493,458	4,493,458
Christine Ocampo See Remarks - [O]	23,160	23,160
Walter C Ogier	20,000
OrbiMed Israel BioFund GP Limited Partnership Director, 10% Owner - [D] [10%]	73,650	73,650
OrbiMed Israel GP Ltd. 10% Owner - [10%]	73,650	73,650
Steven Perrin President, Director - [D] [O]	1,000	1,000
Gerald E Quirk	62,000
Robinson James A. Jr. Director - [D]	3,430	3,430
Muneer A Satter 10% Owner - [10%]	1,771,688	1,771,688
Smith Bryan E.	120,000
Turkel Catherine C. President - [O]	88,662	88,662
Martin D Williams 10% Owner - [10%]	337,700	337,700
Paul Yook 10% Owner - [10%]	1,065,867	1,065,867
Yanchik Joseph A., III Director - [D]	51,092	51,092

Report errors via our new Insider Auditing Tool

追蹤內部人士買入記錄 - 短期收益分析

在這一部分，我們分析了在 ELDN / Eledon Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	內部人士	報告股數	報告價格	經調整股數	經調整價格	成本基礎	達到最高利潤的天數	達到最高利潤時的價格
2024-05-09	BVF PARTNERS L P/IL	1,031,385		1,031,385			176	5.3000
2024-05-09	BVF PARTNERS L P/IL	821,121		821,121
2024-05-09	BVF PARTNERS L P/IL	75,431		75,431
2023-05-05	BVF PARTNERS L P/IL	1,055,445		1,055,445
2023-05-05	BVF PARTNERS L P/IL	837,146		837,146
2023-05-05	BVF PARTNERS L P/IL	86,341		86,341
2022-11-23	Perrin Steven	1,000	2.5969	1,000	2.5969	2,597
2021-12-20	Gros David-Alexandre C	2,000	4.4800	2,000	4.4800	8,960
2021-08-17	Gros David-Alexandre C	4,000	6.2100	4,000	6.2100	24,840

經調整價格已按拆股調整。經調整股數已按拆股調整。

ELDN / Eledon Pharmaceuticals, Inc. Insider Trades

追蹤內部人士賣出記錄 - 短期虧損分析

在這一部分，我們分析了在 ELDN / Eledon Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	內部人士	報告股數	報告價格	經調整股數	經調整價格	成本基礎	達到最低利潤的天數	達到最低利潤時的價格	避免的最高損失金額($)	避免的最高損失率($)
2020-12-02	OrbiMed Israel GP Ltd.	103,200	21.6000	103,200	21.6000	2,229,120	22	13.8100	-803,928	-36.06
2020-10-30	Logos Global Management LP	27	27.0200	27	27.0200	730
2020-10-30	Logos Global Management LP	12,942	26.6442	12,942	26.6442	344,829
2019-05-21	TURKEL CATHERINE C.	1,914	1.9114	106	34.4052	3,658
2019-05-21	FLESHER GREGORY J.	2,937	1.9114	163	34.4052	5,614

經調整價格已按拆股調整。經調整股數已按拆股調整。

交易歷史

點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易，將在標記為 10b-5 的欄位中顯示 X。

呈報日期	交易日期	表格	內部人士	證券代碼	證券種類	代碼	直接	行使價格	單位價格	股數變化	價值變化 (1K)	剩餘期權	剩餘股份
2026-01-16	2026-01-10	4	Robinson James A. Jr.	ELDN	Common Stock	M - Exercise	D			3,430			3,430
2026-01-16	2026-01-10	4	Lee June	ELDN	Common Stock	M - Exercise	D			3,430			3,430
2026-01-16	2026-01-10	4	Katkin Keith	ELDN	Common Stock	M - Exercise	D			8,575			8,575
2026-01-16	2026-01-10	4	Kirk Allan	ELDN	Common Stock	M - Exercise	D			3,430			3,430
2026-01-16	2026-01-10	4	Hillson Jan	ELDN	Common Stock	M - Exercise	D			3,430			3,430
2026-01-16	2026-01-10	4	McBride John S.	ELDN	Common Stock	M - Exercise	D			3,430			3,430
2024-05-13	2024-05-09	4	BVF PARTNERS L P/IL	ELDN	Common Stock, $0.001 par value	P - Purchase	D			75,431			220,460
2024-05-13	2024-05-09	4	BVF PARTNERS L P/IL	ELDN	Common Stock, $0.001 par value	P - Purchase	D			821,121			2,633,679
2024-05-13	2024-05-09	4	BVF PARTNERS L P/IL	ELDN	Common Stock, $0.001 par value	P - Purchase	D			1,031,385			3,361,803
2023-05-09	2023-05-05	4	BVF PARTNERS L P/IL	ELDN	Common Stock, $0.001 par value	P - Purchase	D			86,341			145,029
2023-05-09	2023-05-05	4	BVF PARTNERS L P/IL	ELDN	Common Stock, $0.001 par value	P - Purchase	D			837,146			1,812,558
2023-05-09	2023-05-05	4	BVF PARTNERS L P/IL	ELDN	Common Stock, $0.001 par value	P - Purchase	D			1,055,445			2,330,418
2022-11-23	2022-11-23	4	Perrin Steven	ELDN	Common Stock	P - Purchase	D		2.5969	1,000	3		1,000
2022-02-02	2022-02-01	4	Gros David-Alexandre C	ELDN	Stock Option (right to buy)	A - Award	D	3.97		108,000		108,000
2022-02-02	2022-02-01	4	Smith Bryan E.	ELDN	Stock Option (right to buy)	A - Award	D	3.97		120,000		120,000
2022-02-02	2022-02-01	4	Ogier Walter C	ELDN	Stock Option (right to buy)	A - Award	D	3.97		20,000		20,000
2022-02-02	2022-02-01	4	Perrin Steven	ELDN	Stock Option (right to buy)	A - Award	D	3.97		155,000		155,000
2022-02-02	2022-02-01	4	McBride John S.	ELDN	Stock Option (right to buy)	A - Award	D	3.97		20,000		20,000
2022-02-02	2022-02-01	4	LYONS GARY A	ELDN	Stock Option (right to buy)	A - Award	D	3.97		20,000		20,000
2022-02-02	2022-02-01	4	Lee June	ELDN	Stock Option (right to buy)	A - Award	D	3.97		20,000		20,000
2022-02-02	2022-02-01	4	Hillson Jan	ELDN	Stock Option (right to buy)	A - Award	D	3.97		20,000		20,000
2022-02-02	2022-02-01	4	Katkin Keith	ELDN	Stock Option (right to buy)	A - Award	D	3.97		20,000		20,000
2022-02-02	2022-02-01	4	Little Paul Sean	ELDN	Stock Option (right to buy)	A - Award	D	3.97		155,000		155,000
2022-01-31		3	LAMPERT MARK N	ELDN	Common Stock, $0.001 par value		D						975,412
2022-01-31		3	LAMPERT MARK N	ELDN	Common Stock, $0.001 par value		D						1,274,973
2022-01-31		3	LAMPERT MARK N	ELDN	Common Stock, $0.001 par value		D						58,688
2021-12-21	2021-12-20	4	Gros David-Alexandre C	ELDN	Common Stock	P - Purchase	D		4.4800	2,000	9		9,000
2021-08-19	2021-08-17	4	Gros David-Alexandre C	ELDN	Common Stock	P - Purchase	D		6.2100	4,000	25		7,000
2021-06-14	2021-06-11	4	Little Paul Sean	ELDN	Common Stock	P - Purchase	D		8.8700	10,000	89		10,000
2021-06-10	2021-06-09	4	Gros David-Alexandre C	ELDN	Common Stock	P - Purchase	D		8.0100	3,000	24		3,000
2021-05-04	2021-05-03	4	Smith Bryan E.	ELDN	Stock Option (Right to Buy)	A - Award	D	9.91		158,500		158,500
2020-12-28	2020-12-22	4	BVF PARTNERS L P/IL	NVUS	Series X1 Convertible Preferred Stock	C - Conversion	D			-1,757		6,758
2020-12-28	2020-12-22	4	BVF PARTNERS L P/IL	NVUS	Series X1 Convertible Preferred Stock	C - Conversion	D			-9,169		39,693
2020-12-28	2020-12-22	4	BVF PARTNERS L P/IL	NVUS	Series X1 Convertible Preferred Stock	C - Conversion	D			-11,776		52,145
2020-12-28	2020-12-22	4	BVF PARTNERS L P/IL	NVUS	Series X Convertible Preferred	C - Conversion	D			-35		0
2020-12-28	2020-12-22	4	BVF PARTNERS L P/IL	NVUS	Series X Convertible Preferred	C - Conversion	D			-203		0
2020-12-28	2020-12-22	4	BVF PARTNERS L P/IL	NVUS	Series X Convertible Preferred	C - Conversion	D			-273		0
2020-12-28	2020-12-22	4	BVF PARTNERS L P/IL	NVUS	Common Stock, $0.001 par value	C - Conversion	D			97,615			113,152
2020-12-28	2020-12-22	4	BVF PARTNERS L P/IL	NVUS	Common Stock, $0.001 par value	C - Conversion	D			1,944			15,537
2020-12-28	2020-12-22	4	BVF PARTNERS L P/IL	NVUS	Common Stock, $0.001 par value	C - Conversion	D			509,410			598,624
2020-12-28	2020-12-22	4	BVF PARTNERS L P/IL	NVUS	Common Stock, $0.001 par value	C - Conversion	D			11,278			89,214
2020-12-28	2020-12-22	4	BVF PARTNERS L P/IL	NVUS	Common Stock, $0.001 par value	C - Conversion	D			654,215			771,780
2020-12-28	2020-12-22	4	BVF PARTNERS L P/IL	NVUS	Common Stock, $0.001 par value	C - Conversion	D			15,166			117,565
2020-12-04	2020-12-02	4	OrbiMed Israel GP Ltd. See Footnotes	NVUS	Common Stock	S - Sale	I		21.6000	-103,200	-2,229		73,650
2020-11-06	2020-10-30	4	Logos Global Management LP See Notes 1 and 2	NVUS	Common Stock	P - Purchase	I		25.5507	9,098	232		224,071
2020-11-06	2020-10-30	4	Logos Global Management LP See Notes 1 and 2	NVUS	Common Stock	P - Purchase	I		26.1740	15,000	393		214,973
2020-11-06	2020-10-30	4	Logos Global Management LP See Notes 1 and 2	NVUS	Common Stock	S - Sale	I		27.0200	-27	-1		199,973
2020-11-06	2020-10-30	4	Logos Global Management LP See Notes 1 and 2	NVUS	Common Stock	P - Purchase	I		25.8790	12,942	335		200,000
2020-11-06	2020-10-30	4	Logos Global Management LP See Notes 1 and 2	NVUS	Common Stock	S - Sale	I		26.6442	-12,942	-345		187,058
2020-11-06	2020-10-30	4	Logos Global Management LP See Notes 1 and 2	NVUS	Common Stock	P - Purchase	I		26.4824	15,000	397		200,000
2020-11-06	2020-10-30	4	Logos Global Management LP See Notes 1 and 2	NVUS	Common Stock	P - Purchase	I		25.9730	4,000	104		185,000
2020-11-06	2020-10-30	4	Logos Global Management LP See Notes 1 and 2	NVUS	Common Stock	P - Purchase	I		24.5299	31,000	760		181,000
2020-11-06	2020-10-30	4	Logos Global Management LP See Notes 1 and 2	NVUS	Common Stock	P - Purchase	I		24.0325	5,000	120		150,000
2020-11-06		3	Logos Global Management LP See Notes 1 and 2	NVUS	Common Stock		I						145,000
2020-10-05		3	LAMPERT MARK N	NVUS	Common Stock		D						77,936
2020-10-05		3	LAMPERT MARK N	NVUS	Common Stock		D						102,400
2020-10-05		3	LAMPERT MARK N	NVUS	Common Stock		D						13,595
2020-09-15	2020-09-11	4	LYONS GARY A	NVUS	Stock Option (Right to Buy)	A - Award	D	500.00		1,167		1,167
2020-09-15	2020-09-11	4	McBride John S.	NVUS	Stock Option (Right to Buy)	A - Award	D	500.00		1,167		1,167
2020-09-15	2020-09-11	4	Kuwahara Jon	NVUS	Stock Option (Right to Buy)	A - Award	D	500.00		2,145		2,145
2020-09-15	2020-09-11	4	Katkin Keith	NVUS	Stock Option (Right to Buy)	A - Award	D	500.00		5,907		5,907
2020-09-15	2020-09-11	4	Gros David-Alexandre C	NVUS	Stock Option (Right to Buy)	A - Award	D	500.00		18,278		18,278
2020-03-20	2020-03-19	4	Kuwahara Jon	NVUS	Stock Option (Right to Buy)	A - Award	D	0.26		50,000		50,000
2020-03-20	2020-03-19	4	TURKEL CATHERINE C.	NVUS	Stock Option (Right to Buy)	A - Award	D	0.26		100,000		100,000
2020-03-20	2020-03-19	4	FLESHER GREGORY J.	NVUS	Stock Option (Right to Buy)	A - Award	D	0.26		200,000		200,000
2020-02-25	2020-01-14	4	Chimovits Erez See Footnotes	NVUS	Warrants to Purchase Common Stock	S - Sale	I		0.2000	646,204	129	0
2020-02-25	2020-01-14	4	Chimovits Erez See Footnotes	NVUS	Warrants to Purchase Common Stock	S - Sale	I		0.2000	646,204	129	0
2020-02-25	2020-01-14	4	OrbiMed Israel GP Ltd. See Footnotes	NVUS	Warrants to Purchase Common Stock	S - Sale	I		0.2000	646,204	129
2020-02-25	2020-01-14	4	OrbiMed Israel GP Ltd. See Footnotes	NVUS	Warrants to Purchase Common Stock	S - Sale	I		0.2000	646,204	129
2019-09-30	2019-09-26	4	FLESHER GREGORY J.	NVUS	Stock Option (Right to Buy)	A - Award	D	0.67		100,000		100,000
2019-09-30	2019-09-26	4	TURKEL CATHERINE C.	NVUS	Stock Option (Right to Buy)	A - Award	D	0.67		75,000		75,000
2019-09-30	2019-09-26	4	Kuwahara Jon	NVUS	Stock Option (Right to Buy)	A - Award	D	0.67		60,000		60,000
2019-07-15	2019-07-11	4	Chimovits Erez	NVUS	Stock Option (Right to Buy)	A - Award	D	0.88		20,000		20,000
2019-07-15	2019-07-11	4	Katkin Keith	NVUS	Stock Option (Right to Buy)	A - Award	D	0.88		20,000		20,000
2019-07-15	2019-07-11	4	McBride John S.	NVUS	Stock Option (Right to Buy)	A - Award	D	0.88		20,000		20,000
2019-07-15	2019-07-11	4	Cohen Cheryl	NVUS	Stock Option (Right to Buy)	A - Award	D	0.88		20,000		20,000
2019-07-15	2019-07-11	4	LYONS GARY A	NVUS	Stock Option (Right to Buy)	A - Award	D	0.88		20,000		20,000
2019-05-22	2019-05-21	4	FLESHER GREGORY J.	NVUS	Common Stock	S - Sale	D		1.9114	-2,937	-6		156,918
2019-05-22	2019-05-20	4	FLESHER GREGORY J.	NVUS	Common Stock	S - Sale	D		1.9616	-11,701	-23		159,855
2019-05-22	2019-05-21	4	Kuwahara Jon	NVUS	Common Stock	S - Sale	D		1.9114	-1,058	-2		5,974
2019-05-22	2019-05-20	4	Kuwahara Jon	NVUS	Common Stock	S - Sale	D		1.9616	-4,218	-8		7,032
2019-05-22	2019-05-21	4	TURKEL CATHERINE C.	NVUS	Common Stock	S - Sale	D		1.9114	-1,914	-4		88,662
2019-05-22	2019-05-20	4	TURKEL CATHERINE C.	NVUS	Common Stock	S - Sale	D		1.9616	-7,623	-15		90,576
2019-05-06	2019-05-02	4	Chimovits Erez See Footnotes	NVUS	Warrants to Purchase Common Stock	P - Purchase	I			646,204		646,204
2019-05-06	2019-05-02	4	Chimovits Erez See Footnotes	NVUS	Warrants to Purchase Common Stock	P - Purchase	I			646,204		646,204
2019-05-06	2019-05-02	4	Chimovits Erez	NVUS	Common Stock	P - Purchase	I		3.1000	646,204	2,003		3,183,314
2019-05-06	2019-05-02	4	OrbiMed Israel GP Ltd. See Footnotes	NVUS	Warrants to Purchase Common Stock	P - Purchase	I			646,204		646,204
2019-05-06	2019-05-02	4	OrbiMed Israel GP Ltd. See Footnotes	NVUS	Warrants to Purchase Common Stock	P - Purchase	I			646,204		646,204
2019-05-06	2019-05-02	4	OrbiMed Israel GP Ltd. See Footnotes	NVUS	Common Stock	P - Purchase	I		3.1000	646,204	2,003		3,183,314
2019-05-02	2019-04-30	4	LIFESCI INDEX PARTNERS LLC	NVUS	Common Stock, par value $0.01 per share	S - Sale	I		2.7000	-200	-1		1,065,867
2019-03-18	2019-03-14	4	Kuwahara Jon	NVUS	Stock Option (Right to Buy)	A - Award	D	3.72		25,000		25,000
2019-03-18	2019-03-14	4	FLESHER GREGORY J.	NVUS	Stock Option (Right to Buy)	A - Award	D	3.72		90,000		90,000
2019-03-18	2019-03-14	4	FLESHER GREGORY J.	NVUS	Common Stock	A - Award	D			25,000			171,556
2019-03-18	2019-03-14	4	TURKEL CATHERINE C.	NVUS	Stock Option (Right to Buy)	A - Award	D	3.72		50,000		50,000
2019-03-18	2019-03-14	4	TURKEL CATHERINE C.	NVUS	Common Stock	A - Award	D			20,000			98,199
2018-09-13	2018-09-12	4	TURKEL CATHERINE C.	NVUS	Common Stock	P - Purchase	D		5.0190	16,632	83		78,199
2018-09-13	2018-09-11	4	TURKEL CATHERINE C.	NVUS	Common Stock	P - Purchase	D		4.5560	17,048	78		61,567
2018-09-07	2018-09-05	4	TURKEL CATHERINE C. By Spouse's IRA	NVUS	Common Stock	P - Purchase	I		3.9660	805	3		805
2018-06-14	2018-06-13	4	McBride John S.	NVUS	Stock Option (Right to Buy)	A - Award	D	6.18		9,100		9,100
2018-06-14	2018-06-13	4	Katkin Keith	NVUS	Stock Option (Right to Buy)	A - Award	D	6.18		9,100		9,100
2018-06-14	2018-06-13	4	LYONS GARY A	NVUS	Stock Option (Right to Buy)	A - Award	D	6.18		9,100		9,100
2018-06-14	2018-06-13	4	Cohen Cheryl	NVUS	Stock Option (Right to Buy)	A - Award	D	6.18		9,100		9,100
2018-03-20		3	LIFESCI INDEX PARTNERS LLC	NVUS	Common Stock, $.001 par value		I						2,132,134
2018-03-20		3	LIFESCI INDEX PARTNERS LLC	NVUS	Common Stock, $.001 par value		I						2,132,134
2018-03-20		3	LIFESCI INDEX PARTNERS LLC	NVUS	Common Stock, $.001 par value		I						2,132,134
2018-03-20		3	LIFESCI INDEX PARTNERS LLC	NVUS	Common Stock, $.001 par value		I						2,132,134
2018-03-15	2018-03-13	4	TURKEL CATHERINE C.	NVUS	Stock Option (Right to Buy)	A - Award	D	4.83		24,000		24,000
2018-03-15	2018-03-13	4	TURKEL CATHERINE C.	NVUS	Common Stock	A - Award	D			20,000			44,519
2018-03-15	2018-03-13	4	FLESHER GREGORY J.	NVUS	Stock Option (Right to Buy)	A - Award	D	4.83		56,500		56,500
2018-03-15	2018-03-13	4	FLESHER GREGORY J.	NVUS	Common Stock	A - Award	D			30,700			146,556
2018-03-15	2018-03-13	4	Kuwahara Jon	NVUS	Stock Option (Right to Buy)	A - Award	D	4.83		12,000		12,000
2018-03-15	2018-03-13	4	Kuwahara Jon	NVUS	Common Stock	A - Award	D			11,250			11,250
2017-11-06	2017-11-06	4	TURKEL CATHERINE C.	NVUS	Stock Option (Right to Buy)	A - Award	D	4.21		50,000		50,000
2017-07-10	2017-07-10	4	Kuwahara Jon	NVUS	Stock Option (Right to Buy)	A - Award	D	5.61		35,000		35,000
2017-07-05	2017-06-30	4	Katkin Keith	NVUS	Stock Option (Right to Buy)	A - Award	D	5.85		36,000		36,000
2017-07-05	2017-06-30	4	Morrison Jodie Pope	NVUS	Stock Option (Right to Buy)	A - Award	D	5.85		18,000		18,000
2017-07-05	2017-06-30	4	Cohen Cheryl	NVUS	Stock Option (Right to Buy)	A - Award	D	5.85		18,000		18,000
2017-07-05	2017-06-30	4	McBride John S.	NVUS	Stock Option (Right to Buy)	A - Award	D	5.85		18,000		18,000
2017-07-05	2017-06-30	4	LYONS GARY A	NVUS	Stock Option (Right to Buy)	A - Award	D	5.85		18,000		18,000
2017-05-26	2017-05-24	4	OCAMPO CHRISTINE	NVUS	Stock Option (Right to Buy)	A - Award	D	5.50		52,500		52,500
2017-05-26	2017-05-24	4	TURKEL CATHERINE C.	NVUS	Stock Option (Right to Buy)	A - Award	D	5.50		52,500		52,500
2017-05-26	2017-05-24	4	FLESHER GREGORY J.	NVUS	Stock Option (Right to Buy)	A - Award	D	5.50		250,000		250,000
2017-05-11		3	LYONS GARY A	NVUS	No Securities Owned		D						0
2017-05-11		3	FLESHER GREGORY J.	NVUS	Common Stock		D						113,794
2017-05-11		3	FLESHER GREGORY J.	NVUS	Common Stock		D						113,794
2017-05-11		3	TURKEL CATHERINE C.	NVUS	Common Stock		D						26,816
2017-05-11		3	TURKEL CATHERINE C.	NVUS	Common Stock		D						26,816
2017-05-11		3	Katkin Keith	NVUS	Common Stock		D						24,238
2017-05-11		3	Katkin Keith	NVUS	Common Stock		D						24,238
2017-05-11		3	OCAMPO CHRISTINE	NVUS	Common Stock		D						23,160
2017-05-11		3	OCAMPO CHRISTINE	NVUS	Common Stock		D						23,160
2017-05-11		3	Chimovits Erez By OrbiMed Israel GP Ltd.	NVUS	Common Stock		I						5,074,220
2017-05-11		3	Chimovits Erez By OrbiMed Israel GP Ltd.	NVUS	Common Stock		I						5,074,220
2017-05-11	2017-05-10	4	FLESHER GREGORY J.	NVUS	Common Stock	P - Purchase	D		9.9900	58,959	589		115,856
2017-05-11	2017-05-10	4	OCAMPO CHRISTINE	NVUS	Common Stock	P - Purchase	D		9.9900	10,010	100		21,590
2017-05-11	2017-05-10	4	TURKEL CATHERINE C.	NVUS	Common Stock	P - Purchase	D		9.9900	11,111	111		24,519
2017-05-11	2017-05-09	4	OrbiMed Israel GP Ltd. See Footnotes	NVUS	Common Stock	A - Award	I			2,537,110			2,537,110
2016-06-16	2016-06-15	4	BARBERICH TIMOTHY J	TKAI	Stock Option (right to buy)	A - Award	D	6.29		12,000		12,000
2016-06-16	2016-06-15	4	Harrison Seth Loring	TKAI	Stock Option (right to buy)	A - Award	D	6.29		12,000		12,000
2016-06-16	2016-06-16	4	Cohen Cheryl	TKAI	Stock Option (right to buy)	A - Award	D	6.29		12,000		12,000
2016-06-16	2016-06-15	4	Buckley Stephen Jr.	TKAI	Stock Option (right to buy)	A - Award	D	6.29		12,000		12,000
2016-06-16	2016-06-15	4	Yanchik Joseph A., III	TKAI	Stock Option (right to buy)	A - Award	D	6.29		12,000		12,000
2016-06-16	2016-06-15	4	Kessler David A.	TKAI	Stock Option (right to buy)	A - Award	D	6.29		12,000		12,000
2016-03-15	2016-03-15	4	Buckley Stephen Jr.	TKAI	Common Stock	P - Purchase	D		5.7400	8,000	46		11,000
2016-01-08	2016-01-08	4	Morrison Jodie Pope	TKAI	Stock Option (right to buy)	M - Exercise	D	1.37		-20,000		37,878
2016-01-08	2016-01-08	4	Morrison Jodie Pope	TKAI	Stock Option (right to buy)	M - Exercise	D	0.63		-8,015		0
2016-01-08	2016-01-08	4	Morrison Jodie Pope	TKAI	Common Stock	M - Exercise	D		1.3700	20,000	27		57,566
2016-01-08	2016-01-08	4	Morrison Jodie Pope	TKAI	Common Stock	M - Exercise	D		0.6300	8,015	5		37,566
2015-12-17	2015-12-15	4	Ferrante Karen Jean	TKAI	Stock Option (right to buy)	A - Award	D	9.65		62,000		62,000
2015-12-17	2015-12-15	4	Morrison Jodie Pope	TKAI	Stock Option (right to buy)	A - Award	D	9.65		189,000		189,000
2015-12-17	2015-12-15	4	Kalowski Lee	TKAI	Stock Option (right to buy)	A - Award	D	9.65		62,000		62,000
2015-12-17	2015-12-15	4	McBride John S.	TKAI	Stock Option (right to buy)	A - Award	D	9.65		62,000		62,000
2015-12-17	2015-12-15	4	Quirk Gerald E	TKAI	Stock Option (right to buy)	A - Award	D	9.65		62,000		62,000
2015-11-12	2015-11-11	4	Buckley Stephen Jr.	TKAI	Common Stock	P - Purchase	D		11.2500	3,000	34		3,000
2015-09-22	2015-09-21	4	McBride John S.	TKAI	Stock Option (right to buy)	M - Exercise	D	4.19		-13,500		186,678
2015-09-22	2015-09-21	4	McBride John S.	TKAI	Common Stock	S - Sale	D		14.0100	-13,500	-189		0
2015-09-22	2015-09-21	4	McBride John S.	TKAI	Common Stock	M - Exercise	D		4.1900	13,500	57		13,500
2015-09-08	2015-09-08	4	Kalowski Lee	TKAI	Common Stock	S - Sale	D		13.1300	-4,668	-61		40,953
2015-09-04	2015-09-02	4	Kalowski Lee	TKAI	Common Stock	S - Sale	D		12.9600	-2,158	-28		45,621
2015-07-30	2015-07-29	4	Morrison Jodie Pope	TKAI	Stock Option (right to buy)	M - Exercise	D	1.37		-3,000		57,878
2015-07-30	2015-07-29	4	Morrison Jodie Pope	TKAI	Stock Option (right to buy)	M - Exercise	D	0.63		-7,000		8,015
2015-07-30	2015-07-29	4	Morrison Jodie Pope	TKAI	Stock Option (right to buy)	M - Exercise	D	1.58		-564		312,736
2015-07-30	2015-07-29	4	Morrison Jodie Pope	TKAI	Common Stock	M - Exercise	D		1.3700	3,000	4		29,551
2015-07-30	2015-07-29	4	Morrison Jodie Pope	TKAI	Common Stock	M - Exercise	D		0.6300	7,000	4		26,551
2015-07-30	2015-07-29	4	Morrison Jodie Pope	TKAI	Common Stock	S - Sale	D		13.7000	-564	-8		19,551
2015-07-30	2015-07-29	4	Morrison Jodie Pope	TKAI	Common Stock	M - Exercise	D		1.5800	564	1		20,115
2015-07-30	2015-07-28	4	Morrison Jodie Pope	TKAI	Stock Option (right to buy)	M - Exercise	D	1.58		-12,000		313,300
2015-07-30	2015-07-28	4	Morrison Jodie Pope	TKAI	Common Stock	S - Sale	D		13.7000	-12,000	-164		19,551
2015-07-30	2015-07-28	4	Morrison Jodie Pope	TKAI	Common Stock	M - Exercise	D		1.5800	12,000	19		31,551
2015-07-24	2015-07-22	4	Morrison Jodie Pope	TKAI	Stock Option (right to buy)	M - Exercise	D	0.63		-7,426		15,015
2015-07-24	2015-07-22	4	Morrison Jodie Pope	TKAI	Stock Option (right to buy)	M - Exercise	D	2.31		-2,574		0
2015-07-24	2015-07-22	4	Morrison Jodie Pope	TKAI	Common Stock	M - Exercise	D		0.6300	7,426	5		19,551
2015-07-24	2015-07-22	4	Morrison Jodie Pope	TKAI	Common Stock	M - Exercise	D		2.3100	2,574	6		12,125
2015-07-17	2015-07-15	4	Novartis Bioventures Ltd	TKAI	Common Stock	S - Sale	D		14.2580	-3,566	-51		4,493,458
2015-07-15	2015-07-14	4	Novartis Bioventures Ltd	TKAI	Common Stock	S - Sale	D		14.4100	-27,861	-401		4,497,024
2015-07-15	2015-07-13	4	Novartis Bioventures Ltd	TKAI	Common Stock	S - Sale	D		14.2020	-20,611	-293		4,524,885
2015-06-30	2015-06-29	4	Morrison Jodie Pope	TKAI	Stock Option (right to buy)	M - Exercise	D	1.58		-8,000		325,300
2015-06-30	2015-06-29	4	Morrison Jodie Pope	TKAI	Common Stock	S - Sale	D		13.7000	-8,000	-110		9,551
2015-06-30	2015-06-29	4	Morrison Jodie Pope	TKAI	Common Stock	M - Exercise	D		1.5800	8,000	13		17,551
2015-06-30	2015-06-26	4	Morrison Jodie Pope	TKAI	Stock Option (right to buy)	M - Exercise	D	1.58		-8,000		333,300
2015-06-30	2015-06-26	4	Morrison Jodie Pope	TKAI	Common Stock	S - Sale	D		13.8300	-8,000	-111		9,551
2015-06-30	2015-06-26	4	Morrison Jodie Pope	TKAI	Common Stock	M - Exercise	D		1.5800	8,000	13		17,551
2015-06-24	2015-06-24	4	McBride John S.	TKAI	Stock Option (right to buy)	M - Exercise	D	4.19		-300		200,178
2015-06-24	2015-06-24	4	McBride John S.	TKAI	Common Stock	S - Sale	D		14.2000	-300	-4		0
2015-06-24	2015-06-24	4	McBride John S.	TKAI	Common Stock	M - Exercise	D		4.1900	300	1		300
2015-06-24	2015-06-23	4	McBride John S.	TKAI	Stock Option (right to buy)	M - Exercise	D	4.19		-6,700		200,478
2015-06-24	2015-06-23	4	McBride John S.	TKAI	Common Stock	S - Sale	D		14.0000	-6,700	-94		0
2015-06-24	2015-06-23	4	McBride John S.	TKAI	Common Stock	M - Exercise	D		4.1900	6,700	28		6,700
2015-06-24	2015-06-22	4	McBride John S.	TKAI	Stock Option (right to buy)	M - Exercise	D	4.19		-2,000		207,178
2015-06-24	2015-06-22	4	McBride John S.	TKAI	Common Stock	S - Sale	D		14.0200	-2,000	-28		0
2015-06-24	2015-06-22	4	McBride John S.	TKAI	Common Stock	M - Exercise	D		4.1900	2,000	8		2,000
2015-06-19	2015-06-17	4	BARBERICH TIMOTHY J	TKAI	Stock Option (right to buy)	A - Award	D	14.04		12,000		12,000
2015-06-19	2015-06-17	4	Harrison Seth Loring	TKAI	Stock Option (right to buy)	A - Award	D	14.04		12,000		12,000
2015-06-19	2015-06-17	4	Buckley Stephen Jr.	TKAI	Stock Option (right to buy)	A - Award	D	14.04		12,000		12,000
2015-06-19	2015-06-17	4	Yanchik Joseph A., III	TKAI	Stock Option (right to buy)	A - Award	D	14.04		12,000		12,000
2015-06-19	2015-06-17	4	Kessler David A.	TKAI	Stock Option (right to buy)	A - Award	D	14.04		12,000		12,000
2015-06-18	2015-06-16	4	Novartis Bioventures Ltd	TKAI	Common Stock	S - Sale	D		14.2700	-1,120	-16		4,545,496
2015-06-16	2015-06-12	4	Novartis Bioventures Ltd	TKAI	Common Stock	S - Sale	D		14.2000	-5,919	-84		4,561,393
2015-06-16	2014-06-15	4	Novartis Bioventures Ltd	TKAI	Common Stock	S - Sale	D		14.2000	-14,777	-210		4,546,616
2015-06-12	2015-06-11	4	Novartis Bioventures Ltd	TKAI	Common Stock	S - Sale	D		14.2000	-27,875	-396		4,567,312
2015-05-28	2015-05-26	4	Quirk Gerald E	TKAI	Stock Option (right to buy)	A - Award	D	10.81		214,605		214,605
2015-04-20	2015-04-16	4	Kalowski Lee	TKAI	Common Stock	S - Sale	D		13.0000	-4,567	-59		47,779
2015-04-13		3	Cohen Cheryl	TKAI	No securities are beneficially owned		D						0
2015-04-13	2015-04-09	4	Cohen Cheryl	TKAI	Stock Option (right to buy)	A - Award	D	11.08		25,000		25,000
2015-04-06	2015-04-02	4	Kalowski Lee	TKAI	Common Stock	S - Sale	D		11.4500	-2,258	-26		52,346
2015-03-20	2015-03-19	4	Novartis Bioventures Ltd	TKAI	Common Stock	S - Sale	D		14.5000	-46,141	-669		4,595,187
2015-03-20	2015-03-18	4	Novartis Bioventures Ltd	TKAI	Common Stock	S - Sale	D		14.5000	-3,000	-44		4,641,328
2015-01-12		3	Buckley Stephen Jr.	TKAI	No securities are beneficially owned		D						0
2015-01-12	2015-01-08	4	Buckley Stephen Jr.	TKAI	Stock Option (right to buy)	A - Award	D	14.49		25,000		25,000
2014-10-17	2014-10-15	4	Morrison Jodie Pope	TKAI	Stock Option (right to buy)	A - Award	D	13.25		134,134		134,134
2014-10-17	2014-10-15	4	McBride John S.	TKAI	Stock Option (right to buy)	A - Award	D	13.25		50,671		50,671
2014-09-24	2014-09-22	4	Satter Muneer A See footnote.	TKAI	Series E Preferred Stock	C - Conversion	I			-8,013,003		0
2014-09-24	2014-09-22	4	Satter Muneer A See footnote.	TKAI	Series D-3 Preferred Stock	C - Conversion	I			-3,931,085		0
2014-09-24	2014-09-22	4	Satter Muneer A See footnote.	TKAI	Series D-2 Preferred Stock	C - Conversion	I			-457,728		0
2014-09-24	2014-09-22	4	Satter Muneer A See footnote.	TKAI	Series D-1 Preferred Stock	C - Conversion	I			-4,577,315		0
2014-09-24	2014-09-22	4	Satter Muneer A See footnote.	TKAI	Common Stock	P - Purchase	I		15.0000	150,000	2,250		1,771,688
2014-09-24	2014-09-22	4	Satter Muneer A See footnote.	TKAI	Common Stock	C - Conversion	I			1,621,688			1,621,688
2014-09-24	2014-09-22	4	Harrison Seth Loring See footnote.	TKAI	Series E Preferred Stock	C - Conversion	I			-24,199,308		0
2014-09-24	2014-09-22	4	Harrison Seth Loring See footnote.	TKAI	Series D-3 Preferred Stock	C - Conversion	I			-24,046,035		0
2014-09-24	2014-09-22	4	Harrison Seth Loring See footnote.	TKAI	Series D-2 Preferred Stock	C - Conversion	I			-1,539,643		0
2014-09-24	2014-09-22	4	Harrison Seth Loring See footnote.	TKAI	Series D-1 Preferred Stock	C - Conversion	I			-8,711,335		0
2014-09-24	2014-09-22	4	Harrison Seth Loring See footnote.	TKAI	Series C Preferred Stock	C - Conversion	I			-14,604,833		0
2014-09-24	2014-09-22	4	Harrison Seth Loring See footnote.	TKAI	Series B-2 Preferred Stock	C - Conversion	I			-644,786		0
2014-09-24	2014-09-22	4	Harrison Seth Loring See footnote.	TKAI	Series B-1 Preferred Stock	C - Conversion	I			-798,067		0
2014-09-24	2014-09-22	4	Harrison Seth Loring See footnote.	TKAI	Series A Preferred Stock	C - Conversion	I			-4,500,000		0
2014-09-24	2014-09-22	4	Harrison Seth Loring See footnote.	TKAI	Common Stock	P - Purchase	I		15.0000	362,500	5,438		7,912,079
2014-09-24	2014-09-22	4	Harrison Seth Loring See footnote.	TKAI	Common Stock	C - Conversion	I			7,549,570			7,549,579
2014-09-24	2014-09-22	4	Apple Tree Partners II - Annex, L.P.	TKAI	Series E Preferred Stock	C - Conversion	D			-24,199,308		0
2014-09-24	2014-09-22	4	Apple Tree Partners II - Annex, L.P.	TKAI	Series D-3 Preferred Stock	C - Conversion	D			-10,675,613		0
2014-09-24	2014-09-22	4	Apple Tree Partners II - Annex, L.P.	TKAI	Common Stock	P - Purchase	D		15.0000	237,500	3,562		3,568,438
2014-09-24	2014-09-22	4	Apple Tree Partners II - Annex, L.P.	TKAI	Common Stock	C - Conversion	D			3,330,938			3,330,938
2014-09-24	2014-09-22	4	Morrison Jodie Pope	TKAI	Stock Option (right to buy)	A - Award	D	1.58		165,251		165,251
2014-09-24	2014-09-22	4	Novartis Bioventures Ltd	TKAI	Series E Preferred Stock	C - Conversion	D			-15,064,469		0
2014-09-24	2014-09-22	4	Novartis Bioventures Ltd	TKAI	Series D-3 Preferred Stock	C - Conversion	D			-13,222,826		0
2014-09-24	2014-09-22	4	Novartis Bioventures Ltd	TKAI	Series D-2 Preferred Stock	C - Conversion	D			-1,539,643		0
2014-09-24	2014-09-22	4	Novartis Bioventures Ltd	TKAI	Series D-1 Preferred Stock	C - Conversion	D			-15,396,431		0
2014-09-24	2014-09-22	4	Novartis Bioventures Ltd	TKAI	Common Stock	P - Purchase	D		15.0000	325,000	4,875		4,644,328
2014-09-24	2014-09-22	4	Novartis Bioventures Ltd	TKAI	Common Stock	C - Conversion	D			4,319,328			4,319,328
2014-09-24	2014-09-22	4	BARBERICH TIMOTHY J	TKAI	Series E Preferred Stock	C - Conversion	D			-809,955		0
2014-09-24	2014-09-22	4	BARBERICH TIMOTHY J	TKAI	Series D-3 Preferred Stock	C - Conversion	D			-457,731		0
2014-09-24	2014-09-22	4	BARBERICH TIMOTHY J	TKAI	Common Stock	C - Conversion	D			121,077			121,077
2014-09-24	2014-09-22	4	APPLE TREE PARTNERS II LP	TKAI	Series D-3 Preferred Stock	C - Conversion	D			-13,370,422		0
2014-09-24	2014-09-22	4	APPLE TREE PARTNERS II LP	TKAI	Series D-2 Preferred Stock	C - Conversion	D			-1,539,643		0
2014-09-24	2014-09-22	4	APPLE TREE PARTNERS II LP	TKAI	Series D-1 Preferred Stock	C - Conversion	D			-8,711,335		0
2014-09-24	2014-09-22	4	APPLE TREE PARTNERS II LP	TKAI	Series C Preferred Stock	C - Conversion	D			-14,604,833		0
2014-09-24	2014-09-22	4	APPLE TREE PARTNERS II LP	TKAI	Series B-2 Preferred Stock	C - Conversion	D			-644,786		0
2014-09-24	2014-09-22	4	APPLE TREE PARTNERS II LP	TKAI	Series B-1 Preferred Stock	C - Conversion	D			-798,067		0
2014-09-24	2014-09-22	4	APPLE TREE PARTNERS II LP	TKAI	Series A Preferred Stock	C - Conversion	D			-4,500,000		0
2014-09-24	2014-09-22	4	APPLE TREE PARTNERS II LP	TKAI	Common Stock	C - Conversion	D			4,218,632			4,218,641
2014-09-24		3	Apple Tree Partners IV, L.P.	TKAI	Common Stock		D						250,000
2014-09-24		3	Apple Tree Partners IV, L.P.	TKAI	Common Stock		D						250,000
2014-09-18	2014-09-17	4	Kalowski Lee	TKAI	Stock Option (right to buy)	A - Award	D	15.00		218,417		218,417
2014-09-18	2014-09-17	4	Kalowski Lee	TKAI	Common Stock	A - Award	D			54,604			54,604
2014-09-16		3	Morrison Jodie Pope	TKAI	Common Stock		D						19,102
2014-09-16		3	Morrison Jodie Pope	TKAI	Common Stock		D						19,102
2014-09-16		3	APPLE TREE PARTNERS II LP	TKAI	Common Stock		D						18
2014-09-16		3	APPLE TREE PARTNERS II LP	TKAI	Common Stock		D						18
2014-09-16		3	Yanchik Joseph A., III	TKAI	Common Stock		D						51,092
2014-09-16		3	Yanchik Joseph A., III	TKAI	Common Stock		D						51,092
2014-09-16		3	Williams Martin D	TKAI	Common Stock		D						337,700
2014-09-16		3	Williams Martin D	TKAI	Common Stock		D						337,700
2014-09-16		3	Harrison Seth Loring See footnote.	TKAI	Common Stock		I						212,712
2014-09-16		3	Harrison Seth Loring	TKAI	Common Stock		D						425,397
2014-09-16		3	Harrison Seth Loring See footnote.	TKAI	Common Stock		I						212,712
2014-09-16		3	Harrison Seth Loring	TKAI	Common Stock		D						425,397

非衍生或衍生證券的公開市場或私下買入

非衍生或衍生證券的公開市場或私下賣出

公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）

衍生工具轉換

將證券賣出或轉讓回公司

使用從公司收到的證券的一部分來支付行使價或稅務負擔。

內部人士贈送或接收他人贈送公司股票

股權掉期和類似的避險交易

行使或轉換從公司獲得的衍生證券（例如期權）

內部人士透過Form 4自願報告的一筆交易

其他（附有交易描述的腳註）

ELDN / Eledon Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5